Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease

To view the video version of this series, click here.

EP. 1: Prevalence of Diabetic Kidney Disease (DKD)

Aida Vega, MD;Fernando Carnavali, MD

Fernando Carnavali, MD, comments on the prevalence of diabetic kidney disease (DKD) in the United States, the financial burden on patients and the healthcare system, as well as the importance of early detection of kidney disease in patients with diabetes.

EP. 2: Current Screening Guidelines for DKD

Aida Vega, MD;Fernando Carnavali, MD

Aida Vega, MD, and Fernando Carnavali, MD, discuss the limitations of the tools available to clinicians to screen for DKD, such as Kidney Disease: Improving Global Outcomes (KDIGO).

EP. 3: Role of DKD Progression Screening Tools

Aida Vega, MD;Fernando Carnavali, MD

Experts review the role of the urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) in current DKD progression screening practices.

EP. 4: Use of KidneyIntelX in Patients With DKD

Aida Vega, MD;Fernando Carnavali, MD

Experts in diabetic nephropathy present a study of the use of the KidneyIntelX test in patients with DKD.

EP. 5: KidneyIntelX in DKD Study Population Characteristics

Aida Vega, MD;Fernando Carnavali, MD
Aida Vega, MD, and Fernando Carnavali, MD, review the population characteristics of a study involving the use of KidneyIntelX in DKD.

EP. 6: Referral of High- and Low-Risk Groups in DKD

Aida Vega, MD;Fernando Carnavali, MD
Aida Vega, MD, and Fernando Carnavali, MD, discuss the KidneyIntelX study and the rates of referrals of high-risk DKD patients to specialist care.

EP. 7: Improved Diabetes and Kidney Function Control With KidneyIntelX

Aida Vega, MD;Fernando Carnavali, MD
Drs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.